Orivog GM 1mg/500mg/0.3mg Tablet SR
Marketer
Nexkem Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Orivog GM 1mg/500mg/0.3mg Tablet SR
Diabetacrin SR tablets (1mg/500mg/0.3mg) are an anti-diabetic combination medication for adult type 2 diabetes. This formulation helps manage blood glucose levels. Diabetacrin SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is vital, even with controlled blood sugar; abrupt cessation can lead to hyperglycemia, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, which must incorporate a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported is hypoglycemia (low blood sugar). Learn to identify its symptoms—sweating, lightheadedness, headache, tremor—and how to treat it. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are crucial preventative measures. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with periodic blood tests to evaluate blood cell counts and liver function as directed by your doctor.
Uses of Orivog GM 1mg/500mg/0.3mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Orivog GM 1mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Orivog GM 1mg/500mg/0.3mg Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Orivog GM 1mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Orivog GM 1mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Orivog GM 1mg/500mg/0.3mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Orivog GM 1mg/500mg/0.3mg Tablet SR works:
Extended-release Orivog GM tablets (1mg/500mg/0.3mg) contain a triple-drug regimen for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Orivog GM 1mg/500mg/0.3mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Orivog GM 1mg/500mg/0.3mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Orivog GM 1mg/500mg/0.3mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Orivog GM 1mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is contraindicated for those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Orivog GM 1mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. Low initial doses are typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Orivog GM 1mg/500mg/0.3mg Tablet SR :
Should you forget to take a scheduled Orivog GM 1mg/500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orivog GM 1mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently